An observational study in Scoliosis and Quality of Life, sponsored by Acibadem University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 10 Years to 19 Years. Per ClinicalTrials.gov, last updated 2026-06-30.
Sponsored by Acibadem University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 132 studies in Scoliosis with a site in Turkey — 32 open to participants now, 35 under way, none of them phase 3. Scoliosis · Turkey.
Among the 132 studies in Scoliosis with a site in Turkey, this one is the 14th largest by planned enrollment of the 54 observational ones that give a count, is one of 16 that started in 2026, is one of 54 observational ones, reaches primary completion later than 28 of the 34 other live ones, and was the 122nd registered.
660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.
Browse Scoliosis studies →32 of the 132 studies in Scoliosis with a site in Turkey are open now. Recruiting first, the newest first:
Kahramanmaras Sutcu Imam University · Sites in Turkey
Ages 10–17
Bitlis Eren University · Sites in Turkey
Ages 10–18
Bezmialem Vakif University · Sites in Turkey
Ages 10–19 · Healthy volunteers
Bezmialem Vakif University · Sites in Turkey
Ages 10–19
Ankara Yildirim Beyazıt University · Sites in Turkey
Ages 10–18
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.
This study: 10 Years to 19 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
132 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 16 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 84 across 256 observational studies indexed under Scoliosis.
Median enrollment 32 across the 78 interventional studies, 60 across the 54 observational. Of the 90 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 132 have an industry lead sponsor. The 10 most frequent:
Acibadem University is the lead sponsor of 222 studies on the registry; 51 are open to participants now.
Acibadem University has 2 studies filed under Scoliosis — fewer than ten, so there is no comparison to draw.
8 of the studies in Scoliosis with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07909174Kahramanmaras Sutcu Imam UniversityTurkish Adaptation and Validation of the Scoliosis Misconception Scale in Adolescents With Idiopathic Scoliosis | 2026-11 |
| NCT07767591Bezmialem Vakif UniversitySleep Quality in Adolescents With Idiopathic Scoliosis | 2026-12-01 |
| NCT07321600Hacettepe UniversityResisted Inspiratory Muscle Training Applied in Addition to PSSE-Schroth Exercises | 2026-12-02 |
| NCT07676019Acibadem UniversityPsychometric Properties of the Turkish Version of the Staffordshire Adolescent Idiopathic Scoliosis Questionnaire | 2027-01-02 |
| NCT07758712Bezmialem Vakif UniversityEffectiveness of a Horse Riding Simulator in Adolescents With Idiopathic Scoliosis | 2027-01-10 |
Add all 8 to your calendar (.ics) → With an account.
Among the 132 studies in Scoliosis with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Patient-Reported Outcome Measures (PROMs) have gained increasing importance in scoliosis research in recent years. Although widely used instruments such as the Scoliosis Research Society-22 (SRS-22) include domains related to body image, their primary purpose is to assess overall health-related quality of life and functional outcomes. In contrast, the Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis (SQAIS) was specifically developed to provide a more detailed and patient-centered evaluation of body image and perceived deformity in individuals with adolescent idiopathic scoliosis (AIS). However, a Turkish version of the questionnaire with established validity and reliability is not currently available.
Therefore, the aim of the planned master's thesis is to conduct the cultural adaptation of the Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis into Turkish and to evaluate its psychometric properties in adolescents with AIS. The study will involve a systematic process of linguistic translation and cross-cultural adaptation. Subsequently, the validity and reliability of the Turkish version will be assessed through analyses of internal consistency, test-retest reliability, construct validity, and criterion validity.
The findings of this study are expected to provide a valid and reliable instrument for assessing body image and deformity perception among Turkish adolescents with idiopathic scoliosis, thereby contributing an important patient-centered outcome measure to both clinical practice and research.
The study population will consist of adolescents aged 10-19 years with a diagnosis of Adolescent Idiopathic Scoliosis (AIS) who are being followed in orthopedic and rehabilitation clinics
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Other: Turkish Version of the Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis (SQAIS)
Administration of the Turkish version of the Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis to evaluate body image and perceived deformity in adolescents with idiopathic scoliosis.
Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis
The Turkish version of the Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis (SQAIS) will be administered to assess body image and perceived spinal deformity in adolescents with idiopathic scoliosis. The questionnaire consists of items evaluating patients' perceptions of their appearance and scoliosis-related concerns. Item scores are summed to obtain a total score. Higher scores indicate greater body image disturbance, poorer perception of appearance, and a greater perceived impact of scoliosis-related deformity. Test-retest reliability will be evaluated by re-administering the questionnaire 15-21 days after the initial assessment.
Time frame: Baseline (Day 1) and 15-21 days after baseline.
Scoliosis Research Society-22 Questionnaire
The Scoliosis Research Society-22 (SRS-22) questionnaire will be used to assess health-related quality of life in adolescents with idiopathic scoliosis. The questionnaire consists of 22 items distributed across five domains: Function/Activity, Pain, Self-Image/Appearance, Mental Health, and Satisfaction with Management. Items are scored on a 5-point Likert scale. Domain scores and a total score are calculated, with higher scores indicating better health-related quality of life, better function, less pain, more positive self-image, and better mental health.
Time frame: Baseline (Day 1)
Spinal Appearance Questionnaire
The Spinal Appearance Questionnaire (SAQ) will be used to assess patients' perceptions of spinal deformity and body appearance related to scoliosis. The questionnaire consists of appearance-related items evaluating perceptions of trunk shape, posture, asymmetry, and overall spinal appearance. Scores are calculated for individual domains and as a total score. Higher scores indicate a more negative perception of spinal appearance and greater perceived deformity.
Time frame: Baseline (Day 1)
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Jul 2026; primary completion for Jan 2027, 6 months later.
Of 94 non-industry observational studies under Scoliosis, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 99. This study's planned 6 months is below that.
Counting every sponsor, half of 106 studies reached it within 36 months; a quarter within 9 and three quarters within 92.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.